Objective: To avoid unnecessary surgical treatment of small renal masses (SRM, ≤ four cm), a more accurate diagnostic method would be desirable since radiological differentiation between malignant and benign is difficult and nondiagnostic biopsies account from nine to 37%.
INTRODUCTION
Data from the American Cancer Society show a 70% increase in incidence of kidney and renal pelvis cancer between 2000 and 2008 (31200 versus 54390 patients, respectively). [1] A significant part of this increase in renal cancer is attributed to the incidental discovery of small renal masses (≤ four cm), because of higher availability of abdominal imaging techniques such as CT or MRI-scans. [2;3] A disadvantage of these imaging techniques is that often benign renal masses cannot be distinguished from malignant masses and therefore up to 20% -30% of extirpated renal masses smaller than 4 cm appear to be benign on histopathological examination. [4] Although recent studies proclaim renal biopsy to be an accurate diagnostic tool in the evaluation of renal masses [5;6] , still non diagnostic biopsies exist, which consequently leaves room for diagnostic improvement [7] . Furthermore, accurate biopsies are of utmost importance when evaluating the nature of a renal mass during an ablative treatment or in assessing the status of margins in the course of a partial nephrectomy.
Optical coherence tomography (OCT) is the optical equivalent of B-mode ultrasound imaging. Instead of back-reflected sound waves, OCT images are based on backscattered light. Depth-resolved detection of the back-scattered light results in high resolution cross-sectional images with a maximal image depth of 1.5-2 mm.
The maximal imaging depth is due to the loss of signal by scattering and absorption of light within the tissue. This attenuation of OCT signal is directly related to the optical properties of the tissue. Consequently, the attenuation coefficient (µ t ), describing the decay of detected light intensity with depth, can be quantified using OCT by using Beers law [8] . Recent studies demonstrate that quantitative measurement of µ t using OCT indeed is sensitive for changes of optical properties in tissue, as depicted in analysis of atherosclerotic plaque components [9;10] , as a method to distinguish apoptosis and necrosis in human fibroblasts [11] and in thin optical phantom layers [12] .
Because malignant renal tissue displays larger and irregularly shaped nuclei compared to normal tissue [13] , light scattering is expected to be larger, resulting in both changes in morphological appearance in an OCT image and in changes in µ t .
OCT can visualize real-time pathological changes in living kidney of rats both ex vivo [14] and in vivo [15;16] . However, neither of these studies investigated OCT in its ability to distinguish malignant from benign renal tissue in patients with Renal Cell Carcinoma (RCC). Whereas optical spectroscopy has already been evaluated in several studies with promising results in distinguishing benign from malignant renal tumours [17] [18] [19] , until date only one non-peer review promising report on the field of RCC is available. In that report OCT was able to detect structural abnormalities adjacent to and on the capsule of nine histological confirmed renal cell carcinomas [20] .
In order to assess the feasibility of OCT we assess in this pilot study the ex-vivo ability of OCT to distinguish malignant renal tissue from normal renal parenchyma in patients with RCC based on the attenuation coefficients of these tissue types. 
MATERIALS & METHODS

Data collection & sample preparation
OCT analysis
From each tissue sample, one investigator (DMdB) obtained two or three OCT-images, depending on the amount of available tissue (i.e. in total five to six images per patient.). The tissue samples were imaged with a commercially available 50 kHz swept source OCT system (Santec Inner Vision 2000; 10 µm axial resolution, 11 µm lateral resolution, with light with a wavelength around 1300 nm). The OCT-images were stored in order to be analysed at later date. To obtain a quantitative analysis of the OCTimages, the decrease of light intensity per millimetre (attenuation coefficient or 'µ t ', in mm -1 ) of the tissue was determined (fig. 1) as described before, taking into account the apparatus function [21] and the point spread function [8] of the OCT system. When renal capsula was present in a specimen, the attenuation coefficient was measured below the level of the capsula. When performing the analysis, the investigator was blinded for tissue type and definitive pathology of the tissue samples.
Statistical analysis
Standard pathological report was considered as the gold standard for comparison. All data were collected in a SPSS 16.0.1. database and analysed in cooperation with the Biostatistics department of our clinic.
In our analysis we looked at:
1. difference of attenuation coefficient between normal renal parenchyma and RCC tumour tissue across all patients, treating each tissue sample as an independent observation. The determined µ t are presented as median and interquartile range (IQR). Since more than one OCT image was recorded from each patient, multiple values of µ t were available per patient for both normal and tumour tissue (eight patients), or either normal or tumour tissue (14 patients). We therefore calculated the mean µ t +/-SD for each patient and then grouped these values according to the pathology report. In total 59 OCT images were analyzed. The accuracy of individual µ t determinations was derived from the fit statistics. In all cases, the 95% confidence interval on µ t was the two-sided P-value was < 0.05. The other six patients contributed either with normal renal parenchyma (n=5) or tumour (RCC) tissue (n=1). Table 1 describes demographic and pathological data of patients included in the study. 
difference of attenuation coefficient between normal renal parenchyma and RCC
RESULTS
In
Individual patient comparison
Furthermore, in the eight patients with both normal renal parenchyma and RCC tumour tissue, we compared their mean µ t of normal renal parenchyma with their mean µ t of RCC tissue (i.e. patients as their own control). Figure 3 displays the outcomes per patient. No statistically significant difference was found between the mean µ t of normal and RCC tumour tissue (Wilcoxon Signed Ranks Test, p-value = 0.069).
DISCUSSION
Optical Coherence Tomography (OCT) is a non-invasive imaging technique that allows high quality, three-dimensional imaging using optical scattering of biological tissues. The technique showed its power in an experimental setting [9] and is currently clinically used in different medical fields as ophthalmology, cardiology and gastroenterology [22] [23] [24] .
The method provides tissue morphology images at micrometer scale resolution representing a non-invasive, real time, in situ "optical biopsy". In urology most of the reports on OCT focus on bladder and prostate carcinomas. In vivo sensitivity and specificity of 97.5% and 97.9% respectively have been reported for OCT in combination with fluorescence in the diagnosis of bladder urothelial cell carcinoma [25] . Even though OCT has shown to visualise real-time pathological changes in living kidney of rats [15;16] , to date only one report is available showing OCT was able to detect structural abnormalities adjacent to and on the capsule of nine histological confirmed renal cell carcinomas [20] .
As depicted in figure 1 , the structural information in OCT images can be similar for normal and tumour tissue, which makes diagnosis based on structural appearance challenging. The strength of OCT is that in addition to providing a structural image, quantitative measurements of the optical properties of tissues, such as the amount of light attenuation by scattering and absorption, are feasible. We hypothesized that OCT can distinguish normal from malignant renal tissue based on expected differences in the attenuation coefficient (µ t ): the larger and irregularly shaped nuclei that are more abundant in malignant tissue compared to normal renal parenchyma are expected to produce a larger degree of scattering.
Our study shows a significantly higher OCT attenuation coefficient in RCC tissue than in normal renal parenchyma (p= 0.03) when all patients are grouped together ( figure   2 ). Others already have shown, using optical reflectance spectroscopy both solely and in combination with fluorescence imaging [17;18] , that the optical reflectance differs between renal tumour tissue and normal renal parenchyma. Furthermore this difference is also evident when comparing RCCs with oncocytomas [19] , suggesting that optical spectroscopy does not only distinguish between normal and tumour tissue but also between malignant and benign tumours. In the latter study, the optical characteristics of tumour surface were identical to core tumour tissue, suggesting possible application in endoscopic measurements without the need for core biopsies to be performed [19] . However, absolute and highly localized measurements of optical properties are not possible using these techniques. OCT based techniques such as presented in this and other studies [26] can be the bridge between spectroscopic measurements and our present results. In our study, RCC tissue showed in six out of eight patients a higher attenuation coefficient than normal renal parenchyma. In the remaining two patients this observation was reversed (see fig. 3 ). One of these two patients was known with renal insufficiency and the renal parenchyma corresponded to an end-stage kidney. Indeed, differences in OCT images between normal and ischemic renal parenchyma exist [15] and this may have jeopardized the results in this case as well. Other reasons for the lack of difference may be the scarcity of the sample and the relative heterogeneity of the normal renal parenchyma in this sub-cohort.
We recognize the limitations of the present study. First, measurements were conducted ex-vivo, and therefore tissue perfusion was absent and the specimens were stored in saline. Secondly uneven samples were used for comparison between non-tumour renal parenchyma and RCC tissue and for the in-patient comparison. Although either nontumour and tumour tissue were available in all patients, harvesting of both without potential compromise of the standard pathological assessment was not possible in all cases.
Pilot ex vivo studies as the one hereby presented need to be confirmed and do not always preclude successful clinical results. These preliminary results are the first step in the assessment of OCT as a tool in the diagnostic process of renal mass evaluation and have justified the embarkment of a prospective in vivo study to assess possible OCT differences between normal renal parenchyma and renal tumours, and ultimately differentiation between benign and malignant renal masses.
As statistical difference implies a range, overlap could be expected between normal renal parenchyma and benign and malignant renal tumours. Predictive value of a certain attenuation coefficient, and consequent establishment of cut-offs to distinguish between benign and malignant tissue will be necessary. As far as clinical utilities of OCT are concerned, if results are confirmed in vivo, OCT may be a useful tool in assessing surgical margins after partial nephrectomy and eventually development of ultrathin OCT probes may lead to the replacement of the percutaneous needle biopsy by a percutaneous "optical biopsy" without the need for puncturing the tumor.
We therefore conclude that ex vivo OCT attenuation coefficients were different between renal parenchyma and RCC tissue with RCC tissue showing a significant higher attenuation coefficient when all patients were grouped together per tissue type.
Comparison within patients did not show statistically significant differences. However a larger and homogenous sample might be necessary to lead to definitive conclusions.
Based on these results we do not reject our hypothesis and we will continue with invivo OCT analysis and eventually assess the potential of OCT to differentiate between benign and malignant renal tumours.
